Pharmaceutical Strategies in the Treatment of Respiratory Diseases
American Journal of Pharmaceutics · 2025-06-30 · 6 (3) · 25-34
DOI: 10.71465/ajph2742 ↗At a glance
Journal article in American Journal of Pharmaceutics, published online on 2025-06-30. Written by Dr. Ahmed Khan. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis, represent a significant burden on global health. Pharmaceutical strategies have played a critical role in the management and treatment of these diseases. This article provides an in-depth review of current pharmaceutical treatments, including bronchodilators, corticosteroids, biologic therapies, and newer investigational drugs. We also discuss challenges in drug delivery and the future of personalized medicine in the management of respiratory diseases.
Cite
APA
Khan, D. A. (2025). Pharmaceutical Strategies in the Treatment of Respiratory Diseases. American Journal of Pharmaceutics, 6(3), 25-34. https://doi.org/10.71465/ajph2742
Vancouver
Khan DA. Pharmaceutical Strategies in the Treatment of Respiratory Diseases. American Journal of Pharmaceutics. 2025;6(3):25-34. doi:10.71465/ajph2742
BibTeX
@article{Khan2025,
author = {Khan, Dr. Ahmed},
title = {Pharmaceutical Strategies in the Treatment of Respiratory Diseases},
journal = {American Journal of Pharmaceutics},
year = {2025},
volume = {6},
number = {3},
pages = {25--34},
doi = {10.71465/ajph2742}
}
EUVIMED